Inventor

DANIEL B. PATIENCE

Inventor

Overview

4→

Patents

2021–2024

Patent span

Chemistry

Primary field (CPC C)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary

C07DHeterocyclic compounds25%

A61KPreparations for medical, dental or toiletry purposes19%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%

C07BGeneral methods of organic chemistry19%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium13%

Y02PClimate change mitigation technologies in the production or processing of goods6%

PatentTitleYear

11,858,926Inhibiting agents for bruton's tyrosine kinase2024 11,820,760Crystalline polymorphs of Bruton's tyrosine kinase inhibitors2023 11,427,577Inhibiting agents for Bruton's tyrosine kinase2022 11,192,856Process for preparing alpha-carboxamide pyrrolidine derivatives2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021Patents assigned to BIOGEN INC (1)· patent assignee history

2021–2024Based in US· patent location history

2022–2024Patents assigned to BIOGEN MA INC (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
BIOGEN MA INC	3	2022–2024
BIOGEN INC	1	2021

Locations

Location	Patents	Span
US	4	2021–2024